Pharma Intelligence Center News Today

Climate change-induced exacerbations will increase the number of multiple sclerosis cases.

Amar Rajgor and his team at Newcastle University are now planning a 250-patient study to improve laryngeal cancer outcomes.

The IRA adds another hurdle to an already challenging research landscape, according to a study from the Pioneer Institute.

Some companies, however, reported a market capitalisation decline, including Gilead Sciences and Roche.

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.

Summary. This reports provides a data-driven overview of the current and future competitive landscape in PV therapeutics. ...

Summary. This reports provides a data-driven overview of the current and future competitive landscape in mpox therapeutics. ...

Summary. This reports provides a data-driven overview of the current and future competitive landscape in SBS therapeutics. ...

Each month, Outsourced Pharma works in conjunction with PharmSource, part of GlobalData, to present its “Contract Manufacturing: Opportunities...

DUBLIN--(BUSINESS WIRE)--The "Immune Thrombocytopenia (ITP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape" report has been added to ResearchAndMarkets.com's offering.This reports provides a data-driven overview of the current and future competitive landscape in ITP therapeutics.Ke...